We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Akili Inc is a digital medicine company pioneering the development of cognitive treatments through game-changing technologies. Akili Inc is a digital medicine company pioneering the development of cognitive treatments through game-changing technologies.
FY 2023 total revenues of $1.7M, a 420% increase over FY 2022 as EndeavorOTCⓇ gained traction in the market following June 2023 product release Reports fourth quarter 2023 total revenues of $749...
Japanese Product Now Under Review for Nationwide Marketing Approval PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated...
Japanese Product Now Under Review for Nationwide Marketing Approval Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that its Japanese partner Shionogi & Co...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.015 | 6.69642857143 | 0.224 | 0.254 | 0.21 | 102075 | 0.22921007 | CS |
4 | -0.0879 | -26.8889568675 | 0.3269 | 0.328 | 0.21 | 129842 | 0.26084926 | CS |
12 | -0.031 | -11.4814814815 | 0.27 | 0.7384 | 0.1912 | 2581545 | 0.43952867 | CS |
26 | -0.266 | -52.6732673267 | 0.505 | 0.7384 | 0.1912 | 1266315 | 0.43851688 | CS |
52 | -0.991 | -80.5691056911 | 1.23 | 1.67 | 0.1912 | 747023 | 0.59802782 | CS |
156 | -36.521 | -99.3498367791 | 36.76 | 37.5807 | 0.1912 | 601863 | 1.49055784 | CS |
260 | -36.521 | -99.3498367791 | 36.76 | 37.5807 | 0.1912 | 601863 | 1.49055784 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions